MARKET

VIVE

VIVE

Viveve Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5875
-0.0189
-3.12%
Closed 19:33 08/12 EDT
OPEN
0.6199
PREV CLOSE
0.6064
HIGH
0.6200
LOW
0.5800
VOLUME
654.46K
TURNOVER
--
52 WEEK HIGH
18.00
52 WEEK LOW
0.5266
MARKET CAP
9.20M
P/E (TTM)
-0.0148
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVE stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.

EPS

VIVE News

More
Viveve Announces Clearance Of Viveve 2.0 System In Thailand
Benzinga · 07/14 12:31
Moderna's COVID-19 Vaccine And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 07/12 08:52
30 Stocks Moving in Wednesday's Pre-Market Session
Gainers Party City Holdco Inc. (NYSE: PRTY) rose 34.4% to $1.74 in pre-market trading after the company announced it regained compliance with NYSE continued listing standards.
Benzinga · 07/08 11:16
Viveve on go with study of CMRF treatment for stress urinary incontinence
Seeking Alpha - Article · 07/07 14:24
Viveve Announces FDA Approval To Conduct PURSUIT Trial For Improvement Of Stress Urinary Incontinence
Initiation of pivotal PURSUIT trial is targeted for Q4 2020 following pending results from Company's SUI feasibility study, which is evaluating a new sham treatment tip PURSUIT clearance and pending results from the
Benzinga · 07/07 12:29
Viveve Medical Files Prospectus Relates To Potential Offering Of Up To 5M Shares Of Common Stock By Lincoln Park Capital Fund Llc
Benzinga · 06/18 21:43
Heres why Tipiak Société Anonymes (EPA:TIPI) Returns On Capital Matters So Much
Simply Wall St. · 05/29 11:18
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/15 01:52

Industry

Advanced Medical Equipment & Technology
+1.95%
Healthcare Equipment & Supplies
+1.52%

Hot Stocks

Symbol
Price
%Change

About VIVE

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
More

Webull offers kinds of Viveve Medical Inc stock information, including NASDAQ:VIVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVE stock methods without spending real money on the virtual paper trading platform.